M. Andrew Wade - Net Worth and Insider Trading

M. Andrew Wade Net Worth

The estimated net worth of M. Andrew Wade is at least $3 Million dollars as of 2024-05-12. M. Andrew Wade is the CFO of AtriCure Inc and owns about 145,120 shares of AtriCure Inc (ATRC) stock worth over $3 Million. Details can be seen in M. Andrew Wade's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that M. Andrew Wade has not made any transactions after 2020-02-21 and currently still holds the listed stock(s).

Transaction Summary of M. Andrew Wade

To

M. Andrew Wade Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, M. Andrew Wade owns 1 companies in total, including AtriCure Inc (ATRC) .

Click here to see the complete history of M. Andrew Wade’s form 4 insider trades.

Insider Ownership Summary of M. Andrew Wade

Ticker Comapny Transaction Date Type of Owner
ATRC AtriCure Inc 2020-02-21 Vice President & Finance

M. Andrew Wade Latest Holdings Summary

M. Andrew Wade currently owns a total of 1 stock. M. Andrew Wade owns 145,120 shares of AtriCure Inc (ATRC) as of February 21, 2020, with a value of $3 Million.

Latest Holdings of M. Andrew Wade

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRC AtriCure Inc 2020-02-21 145,120 22.30 3,236,176

Holding Weightings of M. Andrew Wade


M. Andrew Wade Form 4 Trading Tracker

According to the SEC Form 4 filings, M. Andrew Wade has made a total of 6 transactions in AtriCure Inc (ATRC) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in AtriCure Inc is the sale of 45,000 shares on February 21, 2020, which brought M. Andrew Wade around $2 Million.

Insider Trading History of M. Andrew Wade

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

M. Andrew Wade Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

M. Andrew Wade Ownership Network

Ownership Network List of M. Andrew Wade

No Data

Ownership Network Relation of M. Andrew Wade


M. Andrew Wade Owned Company Details

What does AtriCure Inc do?

Who are the key executives at AtriCure Inc?

M. Andrew Wade is the Vice President & Finance of AtriCure Inc. Other key executives at AtriCure Inc include SVP & Mktg & Business Develop Justin J Noznesky , Chief Legal Officer Karl S. Dahlquist , and Chief Scientific Officer Vinayak Doraiswamy .

AtriCure Inc (ATRC) Insider Trades Summary

Over the past 18 months, M. Andrew Wade made no insider transaction in AtriCure Inc (ATRC). Other recent insider transactions involving AtriCure Inc (ATRC) include a net sale of 20,620 shares made by Karl S. Dahlquist , a net sale of 4,500 shares made by Justin J Noznesky , and a net sale of 4,313 shares made by Maggie Yuen .

In summary, during the past 3 months, insiders sold 14,616 shares of AtriCure Inc (ATRC) in total and bought 0 shares, with a net sale of 14,616 shares. During the past 18 months, 30,146 shares of AtriCure Inc (ATRC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 30,146 shares.

AtriCure Inc (ATRC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AtriCure Inc Insider Transactions

No Available Data

M. Andrew Wade Mailing Address

Above is the net worth, insider trading, and ownership report for M. Andrew Wade. You might contact M. Andrew Wade via mailing address: 6217 Centre Park Drive, West Chester Oh 45069.

Discussions on M. Andrew Wade

No discussions yet.